Recombinant Human BTN3A1/CD277 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02617P-100UG
Human BTN3A1 on Tris-Bis PAGE under reduced condition. The purity is greater than 95%.
Recombinant Human BTN3A1/CD277 Protein, Active
Beta LifeScience
SKU/CAT #: BLK-02617P-100UG
Collections: Recombinant proteins
Our products are highly customizable to meet your specific needs. You can choose options such as endotoxin removal, liquid or lyophilized forms, preferred tags, and the desired functional sequence range for proteins. Submitting a written inquiry expedites the quoting process.
Product Overview
Description | Recombinant Human BTN3A1/CD277 Protein is expressed from HEK293 with His tag at the C-Terminus.It contains Gln30-Gly254. |
Purity | > 95% as determined by Tris-Bis PAGE;> 95% as determined by HPLC |
Accession | O00481 |
Target Symbol | BTN3A1/CD277 |
Synonyms | CD277; BTN3A1; BTF5; BT3.1; BTN3.1 |
Species | Human |
Expression System | HEK293 |
Tag | C-His |
Expression Range | Gln30-Gly254 |
Mol. Weight | The protein has a predicted MW of 25.3 kDa. Due to glycosylation, the protein migrates to 28-35 kDa based on Tris-Bis PAGE result. |
Form | Lyophilized |
Formulation | Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization. |
Endotoxin | Less than 1EU per ug by the LAL method. |
Activity | Immobilized Human BTN3A1, His Tag at 0.5ug/ml (100ul/Well) on the plate. Dose response curve for Anti-BTN3A1 Antibody, hFc Tag with the EC50 of 7.2ng/ml determined by ELISA. Contact us for detailed testing images. |
Storage | Reconstituted protein stable at -80°C for 12 months, 4°C for 1 week. Use a manual defrost freezer and avoid repeated freeze-thaw cycles. |
Shipping | Shipped at ambient temperature. |
Gene Background | The three butyrophilin BTN3A molecules, BTN3A1, BTN3A2, and BTN3A3, are members of the B7/butyrophilin-like group of Ig superfamily receptors, which modulate the function of T cells. BTN3A1 controls activation of human Vγ9/Vδ2 T cells by direct or indirect presentation of self and nonself phosphoantigens (pAg). |